|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A review of chemotherapy in gastric cancer显示文摘 | Comis RL | 1974 | Cather1974，34，3： | 1 |
| 2 | The current situation: erlotinib (tarceva) and gefitinib (iressa) in non-sma; cell lung cancer显示文摘 | Comis RL | 2005 | Oncologist2005，10，7： | 1 |
| 3 | A review of chemotherapy in gastric cancer显示文摘 | Comis RL Carter SR | 1974 | Cancer1974，34，5： | 1 |
| 4 | Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer:a phase Ⅱ toxicity,response,and survival analysis显示文摘 | Langer CJ Leighton JC Comis RL | 1995 | J Clin Oncol1995，13，： | 1 |
| 5 | A brief history of the research and treatment of lung cancer from 1970 to 2000显示文摘 | Comis RL | 2003 | Int J Clin Oncol2003，8，4： | 1 |
| 6 | Paclitaxel and carboplatin in combination in the treatment of advanced non- small-cell lung cancer; A phase 11 toxicity, response, and survival analysis显示文摘 | Langer CJ Leighton JC Comis RL | 1995 | J Clin Oncol1995，13，8： | 1 |
| 7 | Paclitaxel by 24-houror 1-hour infusion in combination with carboplatin in advanced-no-small cell lung cancer: the Fox chase cancer experience显示文摘 | Langer C3 Leighton JC Comis RL | 1995 | Semin Oncol1995，22，49： | 1 |
| 8 | A brief history of the research and treatment of lung cancer from 1970 to 2000显示文摘 | Comis RL | 2003 | Int JClin Oncol2003，8，4： | 1 |
| 9 | The role of the Eastern Cooperative Oncology Group in establishing standards of cancer care:over 50 years of progress through clinical research 显示文摘 | Giantonio BJ Forastiere AA Comis RL | 2008 | Semin Oncol2008，35，5： | 1 |
| 10 | Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: a phase II toxicity,response,and survival analysis显示文摘 | Langer CJ Leighion JC Comis RL | 1995 | J Clin Oncol1995，13，： | 1 |
| 11 | A review of chemotherapy in gastric cancer显示文摘 | Comis RL Carter SK | 1974 | Cancer1974，34，5： | 1 |
| 12 | Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: A phase Ⅱ toxicity, response, and survival analysis显示文摘 | Langer CJ Leighton JC Comis RL | 1995 | J Clin Oncol1995，13，8： | 1 |
| 13 | The current situation: erlotinib (Tarceva) and gefitinib (Iressa) in non-small cell lung cancer 显示文摘 | Comis RL | 2005 | Oncologist2005，10，7： | 1 |
| 14 | A brief history of the research and treatment of lung cancer from 1970 to 2000显示文摘 | Comis RL | 2003 | Int J Clin Oncol2003，8，4： | 1 |
| 15 | Paclitaxel and carboplatin in combination m treatment of advanced non--small cell lung, A phase Ⅱ toxicity, response, and survival analysis显示文摘 | Langer CJ Leighton JC Comis RL | 1995 | J Clin Oncol1995，13，8： | 1 |
| 16 | Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: A phase Ⅱ toxicity, response,and surviva analysis显示文摘 | Langer CJ Leighton JC Comis RL | 1995 | J Clin Oncol1995，13，8： | 1 |
| 17 | Paclitaxel by 24-hour or 1-hour infusion in combination with carboplatin in advancedno-small cell lung cancer: the Fox chase cancer experience显示文摘 | Langer CJ Leighton JC Comis RL | 1995 | Semin Oncol1995，22，49： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员